title: In vivo ionizing irradiations produce deletions in the hprt gene of human T-lymphocytes.
abstract: The hprt T-lymphocyte cloning assay, which detects mutations occurring in vivo in humans, has been used to examine mutants induced in patients receiving radioimmunoglobulin therapy (RIT) for cancer. Samples from 13 patients before treatment (controls) and 15 samples from 12 patients after treatment were studied for both mutant frequencies and molecular changes in the hprt mutant T-cell clones. Patients were studied up to 48 months after treatment. Post-RIT patients showed increased mutant frequencies as compared to pre-treatment values. T-cell receptor (TCR) gene analysis of mutant T-cell clones demonstrated that 84% arose independently, both pre- and post-treatment, which is the same proportion as seen in normal individuals. However, several individuals did show large sets of mutants with the same TCR gene rearrangement patterns. Molecular analysis of mutants demonstrated a greater proportion of mutations with hprt gene changes on Southern blots after RIT treatment than before (40% versus 20%). RIT increases the proportion of mutations with total rather than partial gene deletions or other gross structural changes compared to normal individuals or pre-treatment patients. These studies are defining the spectrum for radiation-induced hprt gene mutations in vivo in human T-lymphocytes.
authors.affiliation: Vermont Regional Cancer Center, Burlington.
authors.forename: J A
authors.initials: JA
authors.lastname: Nicklas
authors.forename: J P
authors.initials: JP
authors.lastname: O'Neill
authors.forename: T C
authors.initials: TC
authors.lastname: Hunter
authors.forename: M T
authors.initials: MT
authors.lastname: Falta
authors.forename: M J
authors.initials: MJ
authors.lastname: Lippert
authors.forename: D
authors.initials: D
authors.lastname: Jacobson-Kram
authors.forename: J R
authors.initials: JR
authors.lastname: Williams
authors.forename: R J
authors.initials: RJ
authors.lastname: Albertini
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D015139:Blotting, Southern; D002872:Chromosome Deletion; D002999:Clone Cells; D004273:DNA, Neoplasm / Q000235:genetics / Q000528:radiation effects; D005260:Female; D006801:Humans; D007041:Hypoxanthine Phosphoribosyltransferase / Q000235:genetics / Q000528:radiation effects*; D008297:Male; D008875:Middle Aged; D016499:Radioimmunotherapy / Q000009:adverse effects*; D011948:Receptors, Antigen, T-Cell / Q000235:genetics; D013223:Statistics as Topic; D013601:T-Lymphocytes / Q000201:enzymology / Q000528:radiation effects*
chemical_list: D004273:DNA, Neoplasm; D011948:Receptors, Antigen, T-Cell; D007041:Hypoxanthine Phosphoribosyltransferase